Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Randomized, double-blind placebo-controlled phase I study to investigate the safety and tolerability of ascending doses of DM-101 in adult subjects with birch pollen allergy.
Epistemonikos ID: 8b3aaba68a2709ac14589cf2e5a7ec588ddd11d6
First added on: May 07, 2024